Cargando…
Targeting Angiogenesis in Childhood Sarcomas
Angiogenesis and vasculogenesis constitute two processes in the formation of new blood vessels and are essential for progression of solid tumors. Consequently, targeting angiogenesis, and to a lesser extent vasculogenesis, has become a major focus in cancer drug development. Angiogenesis inhibitors...
Autores principales: | Bid, Hemant K., Houghton, Peter J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005857/ https://www.ncbi.nlm.nih.gov/pubmed/21197468 http://dx.doi.org/10.1155/2011/601514 |
Ejemplares similares
-
Link between p53 isoforms and angiogenesis: Current prospects
por: Bid, Hemant Kumar
Publicado: (2013) -
BET bromodomain inhibitor (JQ1) and tumor angiogenesis
por: Bid, Hemant Kumar, et al.
Publicado: (2016) -
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014) -
p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage
por: Cam, Maren, et al.
Publicado: (2014) -
Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule
por: Sugahara, Kazuyuki, et al.
Publicado: (2012)